Senior insider sale
Chief Medical Officer at ICOSAVAX, INC. — senior position signals high conviction
$1.85M
118.26K shares
What this filing means
KANESA-THASAN NIRANJAN plans to sell 118.26K shares of ICOSAVAX, INC. valued at approximately $1.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/4/2024ACC: 0001950047-24-000173
Officer· Chief Medical Officer
Since Jul 2021
118.26K
Shares to sell
$1.85M
Approx. market value
106.37K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
1/4/2024
106.37KTotal acquired106.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2024 | Stock Option Exercise Cash | 106.37K | — |
| Total | 106.37K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
11.88K
Market value
$183.7K
12/20/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
106.37K
Market value
$1.67M
1/4/2024
Total
Units
118.26K
Value
$1.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/20/2023 | 11.88K | $183.7K | — | Completed |
| Planned — Approximate Date | ||||
1/4/2024 | 106.37K | $1.67M | NASDAQ | Planned |
| Total | 118.26K | $1.85M | ||